Labcorp Perspectives: Oncology

Explore the ever-evolving world of cancer care in our insightful content series, Labcorp Perspectives as we delve into the latest advancements in oncology diagnostics and their impact on patient outcomes. Each episode brings together leading oncology experts to discuss:• Groundbreaking research: Uncovering the cutting-edge science shaping the future of cancer treatment• Practical applications: Learning how precision medicine translates from lab to the clinic• Real-world challenges: Exploring the hurdles faced in oncology care and discovering potential solutionsMore than just information, this series fosters collaboration and unbiased education. Labcorp Perspectives not only empowers healthcare professionals and researchers but also patients to stay informed, inspired and at the forefront of medical oncology.

Labcorp Perspectives: Oncology is a health podcast hosted by Labcorp, with 14 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Labcorp hosts Labcorp Perspectives: Oncology, a health show with 14 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #12

  How Molecular Profiling is Changing Cancer Grading

  Jun 4, 202620 minS0

  <p>What does nuclear grading really reveal in the modern molecular era of endometrial cancer care?</p> <p>In this episode of Labcorp Perspectives Oncology, host Dr. Rebecca Previs, Senior Director of Medical Affairs, sits down with gynecologic pathologist Dr. Tricia Newman and anatomic and molecular pathologist Dr. Kyle Strickland to unpack the surprising findings from their USCAP-presented study.</p> <p>Step into the pathologist’s perspective as the team breaks down how tumor grading is performed, why nuclear atypia matters, and the sometimes-conflicting role of molecular testing like MSI and TP53. Discover why grading variability among experts can shift tr...

  ListenShow Notes
• 

  Episode #11

  Advancing Endometrial Cancer Care with Molecular Profiling

  May 14, 202632 minS0

  <p>In this compelling episode of Labcorp Perspectives Oncology, host Dr. Rebecca Previs is joined by innovators Dr. Angeles Alvarez Secord and Dr. Aine Clements to discuss high-impact data on endometrial cancer, focusing on the landmark GOG258 trial through the lens of modern molecular classification.</p> <p>The trio explores how integrating single-gene testing for markers such as POL-E, mismatch repair, and p53 mutations is redefining “high risk,” shifting treatment strategies, and offering new hope for patients with advanced endometrial cancer. Hear first-hand about the years-long research journey, the challenges of trial design, and what practice-changing insights these findings bring to c...

  ListenShow Notes
• 

  Episode #10

  The Pulse of the Oncologist: Listening to What Matters Most

  Apr 14, 202622 minS0

  <p>In this episode of Labcorp Perspectives Oncology, host Dr. Rebecca Previs welcomes Dr. Brian Caveney, Labcorp’s Chief Medical and Scientific Officer, to unpack findings from the Pulse of the Oncologist report—a nationwide survey capturing the real-world perspectives of 152 oncologists across practice settings.</p> <p>Together, Dr. Rebecca Previs and Brian Caveney dive into the pressing issues that shape oncology care today: the rising complexity of cancer treatment, the critical importance of diagnostic turnaround time, and how digital innovation can ease clinical workflows and reduce friction. They discuss why interpretive clarity in lab reports matters more than ever and...

  ListenShow Notes
• 

  Episode #9

  Navigating the Future of CDXs in Oncology

  Feb 18, 202626 minS0

  <p>How are companion diagnostics (CDXs) transforming the landscape of precision oncology? In this episode of Labcorp Perspectives Oncology, host Dr. Rebecca Previs welcomes CDX expert Dawn McHugh, Director of Precision Oncology CDx at Labcorp, for a deep dive into the evolving world of companion diagnostics.</p><p>You’ll learn what defines a true CDX, how it differs from other biomarker tests, and why integrating it with targeted therapies is essential for matching the right patient to the right treatment. Dawn McHugh guides us through real-world examples—from HER2 and EGFR to the latest in liquid biopsy—explaining how these...

  ListenShow Notes
• 

  Episode #8

  FFPE: The Workhorse Behind NGS Testing

  Jan 28, 202634 minS0

  <p>In this episode of Labcorp Perspectives Oncology, host Dr. Rebecca Previs is joined by Dr. Kyle Strickland, Director of Medical Affairs and pathologist at Labcorp, and Dr. Erin Newburn, field application scientist and genomicist, for a deep dive into tissue stewardship and the pivotal role of FFPE specimens in precision oncology.</p><p>Together, the team demystifies how formalin-fixed paraffin-embedded (FFPE) samples have become the gold standard in both clinical and research settings for biomarker testing. They discuss the science behind tissue preservation, compare FFPE to fresh and frozen samples, and reveal the unique challenges these specimens present for...

  ListenShow Notes

Recent guests on Labcorp Perspectives: Oncology. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.